By
U.K. government knew vaccine injuries were expected
https://ift.tt/9m63NjA
U.K. government knew vaccine injuries were expected
- The U.K. government was aware of the potential for serious injuries caused by Pfizer-BioNTech's COVID-19 vaccines before their approval, anticipating indemnity costs ranging from £75 billion to £300 billion.
- The vaccines were not subjected to the usual rigorous, long-term clinical trials, with officials justifying this through an "emergency" rationale, raising concerns about the haste and potential harm.
- Unlike the U.S., the U.K. did not grant pharmaceutical companies full statutory immunity, allowing for potential civil claims and even criminal liability under the Economic Crime and Corporate Transparency Act 2023 (ECCTA).
- The ECCTA introduces new measures for holding large organizations criminally liable for fraudulent activities, including failing to prevent illegal promotion of drugs or misrepresentation of safety data.
- The article emphasizes the need for a full investigation into the decisions made during the pandemic, highlighting the importance of holding pharmaceutical companies accountable for their actions and ensuring transparency and justice.
In a shocking revelation that has sent shockwaves through the U.K., former Secretary of State Alok Sharma has admitted that the government was fully aware of the potential for serious injuries caused by Pfizer-BioNTech’s COVID-19 vaccines before they were approved for public use. Documents presented at the ongoing Covid Inquiry reveal that the government anticipated indemnity costs ranging from £75 billion ($92.36 billion) to a staggering £300 billion ($369.3 billion) to cover vaccine-related injuries. This admission raises serious questions about the ethics of mandating these experimental injections, particularly for children, and the integrity of the pharmaceutical industry’s claims of safety and efficacy.
The £1.7 billion bill: A calculated risk
The Covid Inquiry has laid bare the cold, hard truth: the U.K. government knew that the Pfizer-BioNTech vaccine, rushed through regulatory approval under unprecedented timelines, carried significant risks. According to internal documents, the government estimated a worst-case scenario of £1.7 billion ($2.1 billion) in payouts for vaccine injuries. While this figure pales in comparison to the £300 billion upper limit discussed in initial negotiations with Pfizer, it underscores the fact that officials were well aware of the potential for harm.
The Telegraph reported that the vaccines were not subjected to the rigorous, long-term clinical trials typically required for such medical interventions. This lack of thorough testing was justified under the guise of an “emergency,” but the consequences of this haste are now coming to light. As Mike Fairclough, Britain’s most outspoken headmaster, aptly noted on social media, it was “pure evil” to expose children to such unnecessary risks.
No full immunity: A silver lining for accountability?
Unlike the United States, where pharmaceutical companies were granted full statutory immunity from civil claims, the U.K. government pushed back against Pfizer’s initial demand for complete legal protection. This decision means that, in the U.K., pharmaceutical companies can still be held liable for vaccine-related injuries.
This is a critical distinction. In the U.S., victims of vaccine injuries have little recourse, as pharmaceutical companies are shielded from lawsuits. In the U.K., however, the door remains open for civil claims, and under the Economic Crime and Corporate Transparency Act 2023 (ECCTA), companies can even face criminal liability if they fail to prevent fraudulent activities related to their products.
Fraudulent activities, as defined by the ECCTA, include illegal promotion of drugs, failure to report safety data and manufacturing violations. If it can be proven that Pfizer or other vaccine manufacturers knowingly misrepresented the safety and efficacy of their products, they could face severe legal consequences.
The ECCTA: A new era of corporate accountability
The ECCTA, which came into force in October 2023, represents a significant shift in how corporate fraud is addressed in the United Kingdom. Under Section 199 of the Act, large organizations can be held criminally liable if they fail to implement “reasonable prevention procedures” to stop fraudulent acts committed by individuals associated with them.
The government’s guidance on the ECCTA, published in November 2024, outlines six key principles for businesses to follow:
1. Top-level commitment: Senior management must lead the charge in developing and endorsing fraud prevention measures.
2. Risk assessment: Companies must identify and document potential risks, including opportunities, motivations and rationalizations for fraud.
3. Proportionate prevention procedures: Measures must be tailored to the specific risks faced by the organization.
4. Due diligence: Companies must conduct thorough checks on individuals and entities performing services on their behalf.
5. Communication and training: Policies and procedures must be clearly communicated and reinforced through training.
6. Monitoring and review: Prevention measures must be regularly updated to reflect evolving risks.
For pharmaceutical companies like Pfizer, this means that any failure to disclose known risks or misrepresentation of data could result in criminal prosecution. The guidance makes it clear that what constitutes “reasonable” prevention procedures will be determined by the courts on a case-by-case basis.
A call for justice and transparency
The revelations from the Covid Inquiry are a damning indictment of the government’s handling of the pandemic and its partnership with Big Pharma. The fact that officials were willing to gamble with public health, particularly that of children, for the sake of expediency is nothing short of scandalous.
Natural health advocates have long warned against the dangers of rushed medical interventions and the overreach of pharmaceutical companies. This latest development underscores the importance of holding these corporations accountable for their actions. The ECCTA provides a glimmer of hope, but only if it is enforced rigorously and without bias.
The public deserves transparency, accountability and justice. It is time for a full reckoning of the decisions made during the pandemic and the harm caused by those who placed profit over people. The truth must come to light, and those responsible must be held to account.
Sources include:
news
via NaturalNews.com https://ift.tt/TUOCjSR
January 28, 2025 at 05:14AM
January 28, 2025 at 09:15AM
via NaturalNews.com https://ift.tt/9m63NjA